JP7451005B1 - ヘレナリン誘導体を含有する前駆脂肪細胞の増殖及び／又は分化促進剤 - Google Patents

ヘレナリン誘導体を含有する前駆脂肪細胞の増殖及び／又は分化促進剤 Download PDF

Info

Publication number
JP7451005B1
JP7451005B1 JP2023575625A JP2023575625A JP7451005B1 JP 7451005 B1 JP7451005 B1 JP 7451005B1 JP 2023575625 A JP2023575625 A JP 2023575625A JP 2023575625 A JP2023575625 A JP 2023575625A JP 7451005 B1 JP7451005 B1 JP 7451005B1
Authority
JP
Japan
Prior art keywords
compound
defr
differentiation
proliferation
subjected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023575625A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023223715A1 (https=
JPWO2023223715A5 (https=
Inventor
孝太郎 坂元
徹 光永
恒生 山内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ichimaru Pharcos Co Ltd
Original Assignee
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd
Publication of JPWO2023223715A1 publication Critical patent/JPWO2023223715A1/ja
Application granted granted Critical
Publication of JP7451005B1 publication Critical patent/JP7451005B1/ja
Publication of JPWO2023223715A5 publication Critical patent/JPWO2023223715A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023575625A 2022-05-19 2023-04-11 ヘレナリン誘導体を含有する前駆脂肪細胞の増殖及び／又は分化促進剤 Active JP7451005B1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022082055 2022-05-19
JP2022082055 2022-05-19
PCT/JP2023/014689 WO2023223715A1 (ja) 2022-05-19 2023-04-11 ヘレナリン誘導体を含有する前駆脂肪細胞の増殖及び／又は分化促進剤

Publications (3)

Publication Number Publication Date
JPWO2023223715A1 JPWO2023223715A1 (https=) 2023-11-23
JP7451005B1 true JP7451005B1 (ja) 2024-03-18
JPWO2023223715A5 JPWO2023223715A5 (https=) 2024-04-26

Family

ID=88835358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575625A Active JP7451005B1 (ja) 2022-05-19 2023-04-11 ヘレナリン誘導体を含有する前駆脂肪細胞の増殖及び／又は分化促進剤

Country Status (3)

Country Link
JP (1) JP7451005B1 (https=)
CN (1) CN118103041B (https=)
WO (1) WO2023223715A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011032233A (ja) * 2009-08-04 2011-02-17 Pias Arise Kk 皮膚外用組成物
JP2020023476A (ja) * 2018-07-25 2020-02-13 一丸ファルコス株式会社 前駆脂肪細胞の増殖及び分化促進剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018070533A (ja) * 2016-11-01 2018-05-10 一丸ファルコス株式会社 前駆脂肪細胞増殖促進剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011032233A (ja) * 2009-08-04 2011-02-17 Pias Arise Kk 皮膚外用組成物
JP2020023476A (ja) * 2018-07-25 2020-02-13 一丸ファルコス株式会社 前駆脂肪細胞の増殖及び分化促進剤

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AULD, C.A. et al.，Novel effect of helenalin on Akt signaling and Skp2 expression in 3T3-L1 preadipocytes，Biochemical and Biophysical Research Communications，2006年，Vol.346，p.314-320
AULD, C.A. ET AL.: "Novel effect of helenalin on Akt signaling and Skp2 expression in 3T3-L1 preadipocytes", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 346, JPN6023028422, 2006, pages 314 - 320, ISSN: 0005244468 *
FERNANDES, K.M. et al.，Helenalin-Mediated Post-Transcriptional Regulation of p21(Cip1) Inhibits 3T3-L1 Preadipocyte Prolife，Journal of Cellular Biochemistry，2008年，Vol.105，p.913-921
FERNANDES, K.M. ET AL.: "Helenalin-Mediated Post-Transcriptional Regulation of p21(Cip1) Inhibits 3T3-L1 Preadipocyte Prolife", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 105, JPN6023028421, 2008, pages 913 - 921, ISSN: 0005244467 *

Also Published As

Publication number Publication date
JPWO2023223715A1 (https=) 2023-11-23
CN118103041B (zh) 2025-02-14
CN118103041A (zh) 2024-05-28
WO2023223715A1 (ja) 2023-11-23

Similar Documents

Publication Publication Date Title
KR20030005252A (ko) 피부 외용제 및 미백제
CN107148264A (zh) 拟微绿球藻提取物及其应用
KR20170121468A (ko) 감귤류 과피 추출물을 포함하는 피부 조직 재생용 조성물
JP7450903B2 (ja) 前駆脂肪細胞の増殖及び分化促進剤
JP7451005B1 (ja) ヘレナリン誘導体を含有する前駆脂肪細胞の増殖及び／又は分化促進剤
WO2012002536A1 (ja) Ｖｅｇｆ産生促進剤
JP2008094792A (ja) オオボウシバナ由来のフラボノイドを含有するヒアルロン酸合成促進剤、抗老化剤および皮膚外用剤
JP7589988B2 (ja) プロテアソーム活性化剤
WO2023249046A1 (ja) ヒアルロン酸の構造を維持するための剤
KR102292114B1 (ko) 식물 복합 추출물을 유효성분으로 포함하는 피부 보습, 미세먼지 유발 염증 개선, 및 모공축소용 조성물
JP4076477B2 (ja) 皮膚外用剤
JP3449967B2 (ja) 皮膚外用剤
JP2004307437A (ja) 老化防止用皮膚外用剤
JP2010024190A (ja) 皮膚バリア機能改善剤
JP2010168300A (ja) プロアントシアニジン三量体
JP3754025B2 (ja) 細胞賦活剤、抗酸化剤、及び皮膚外用剤
KR20210095341A (ko) 스피룰리나 추출물을 포함하는 피부재생용 조성물
JP7680990B2 (ja) 肌のくすみ改善剤
KR102748498B1 (ko) 끈끈이대나물 추출물을 함유하는 미세먼지에 의한 피부 손상 예방, 개선 또는 치료용 조성물
JP6923774B1 (ja) 育毛促進用及び／又は白髪改善用組成物
KR102503007B1 (ko) 인간지방줄기세포의 분화 촉진용 조성물
KR20200023163A (ko) 인간지방줄기세포의 분화 촉진용 조성물
JP2024075916A (ja) 皮膚の糖化を抑制するための剤
JP2004137166A (ja) 皮膚外用剤、細胞賦活剤、抗酸化剤
JP2009234936A (ja) 植物由来ポリアミン含有抽出物を含有する化粧品組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231207

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20231207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240207

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240228

R150 Certificate of patent or registration of utility model

Ref document number: 7451005

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150